Search bioRxiv⌕ Search

Biology subjects

De Paepe, B.

Publications and source records attributed to De Paepe, B..

6 recordsLinked to original sources

Systematic mapping of orthogonality and domain-swap permissiveness across LysR-type transcriptional biosensors

Transcription factor-based biosensors monitor metabolites and control genetic programs, but their wider use is constrained by the limited repertoire of characterized, mutually compatible sensor parts. Here we combine a curated screen of natural LysR-type transcriptional regulators (LTTRs), the largest family of bacterial transcription factors, with systematic domain swapping. Using a standardized construction platform, we convert 17 LTTRs into whole-cell reporters in Escherichia coli. Of 16 viable circuits, nine show regulatory activity, including six ligand-inducible biosensors for acetate, benzoate, -ketoglutarate, chlorohydroquinone, L-homocysteine and salicylate. Mapping interactions across 11 LTTR systems identifies seven mutually orthogonal regulator pairs, providing, to our knowledge, the first orthogonality map for this family. We next construct 108 chimeras across three domain-swap architectures; 69 retain measurable activity, with functional outcomes enriched when the native hinge-ligand-binding-domain association is preserved. As proof of principle, we redesign a cross-reactive regulator: replacing its DNA-binding domain with one from an orthogonal regulator abolishes unwanted promoter crosstalk while preserving ligand-inducible activation of its own target, transferring orthogonality to a previously incompatible pair. Together, natural-diversity screening and domain swapping emerge as complementary routes to expand LTTR biosensor repertoires, revealing a strong link between connector architecture and chimera function.

synthetic biology↗

Development and characterisation of a promoter library for Sulfolobus acidocaldarius

The hyperthermoacidophilic archaeon Sulfolobus acidocaldarius is a promising production host for industrial biotechnology applications due to its ability to thrive in extreme conditions. However, the lack of well-characterised genetic parts and tools, particularly promoters, limits its potential for metabolic engineering. In this study, we developed the first promoter library for S. acidocaldarius by randomising specific regions of the core promoter sequence of PSaci 2137, a promoter known to function in both S. acidocaldarius and Escherichia coli. The library was initially screened in E. coli using mKate2, a red fluorescent reporter protein, and seven promoters were selected for characterisation in S. acidocaldarius using the thermostable {beta}-galactosidase reporter LacS. The resulting promoter collection exhibited a 5-fold range of expression levels in S. acidocaldarius, spanning from low to high constitutive expression when compared to S. acidocaldarius promoters Psac7d and PmalE. This study demonstrates a successful workflow for generating and characterising S. acidocaldarius promoters, providing a valuable toolkit for fine-tuning gene expression and optimising metabolic pathways in this extremophilic archaeon. The design principles established here can be extended to other archaeal systems with similar promoter architectures.

synthetic biology↗

An experimentally verified mechanistic model for predicting quorum sensing-based switches

Quorum sensing-based genetic circuits are gaining traction in synthetic biology as they link population-level behaviour to individual cell responses. However, tuning these circuits remains challenging due to complex dynamics, particularly during the Learn phase of the Design-Build-Test-Learn (DBTL) cycle. To accelerate this process, we developed a mathematical model to predict how varying expression levels of the transcription factor and synthase affect the response of the EsaI/EsaR quorum sensing system. A strain library was constructed, and experimental data were used to optimize the model. The final model could successfully differentiate between the effects of these expression levels on the response of the bidirectional promoter. It allowed visualization of all potential system outcomes and emphasized the transcription factors critical role in tuning the circuit. This model offers a valuable tool for fine-tuning EsaI/EsaR-based systems for synthetic biology applications. Moreover, given the homology within the LuxR-family quorum sensing systems, this modelling approach may serve as a foundation for model-based tuning of other quorum sensing systems.

synthetic biology↗

Characterization and orthogonality assessment of two quorum sensing systems for synthetic biology applications

Quorum sensing systems have a broad range of applications within the field of synthetic biology. However, a bottleneck is the optimization and tuning of these systems due to the lack of standardization and complete characterization. In this research, two quorum sensing systems, namely the LasI/LasR and the EsaI/EsaR system, were fully characterized in the model host organism Escherichia coli. Furthermore, insight was gained in the interplay between the various parts of these systems. To further expand the range of possibilities with these quorum sensing systems, the orthogonality of the two systems was assessed to allow simultaneous use within the same cell without interfering crosstalk. This assessment was performed on three levels: promoter, signal and synthase crosstalk. It was demonstrated that LasR is able to interact with the promoter of the EsaI/EsaR system, albeit to a low extent. Additionally, LasR was able to respond to the autoinducers produced by EsaI. To solve the promoter crosstalk, a nucleotide change was introduced into the binding site of EsaR within the promoter region. Additionally, LasR mutants were created rationally and screened for decreased response to EsaI while retaining functionality. The best performing mutant, LasR(P117S), was further characterized. In conclusion, we have further unlocked the potential of quorum sensing systems for synthetic biology applications by obtaining two functional, characterized and orthogonal quorum sensing systems. Highlights- Characterization of two LuxR-type quorum sensing systems - Assessing the orthogonality of the EsaI/EsaR and LasI/LasR quorum sensing system - Eliminating the crosstalk between the EsaI/EsaR and LasI/LasR quorum sensing system

synthetic biology↗

mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Due to a lack of effective treatments, patients with metastatic disease have a median survival time of 6-12 months. We recently demonstrated that the SAMMSON long non-coding RNA (lncRNA) is essential for uveal melanoma cell survival and that antisense oligonucleotide (ASO)-mediated silencing of SAMMSON impaired cell viability and tumor growth in vitro and in vivo. By screening a library of 2911 clinical stage compounds, we identified the mTOR inhibitor GDC-0349 to synergize with SAMMSON inhibition in UM. Mechanistic studies revealed that mTOR inhibition enhanced uptake and reduced lysosomal accumulation of lipid complexed SAMMSON ASOs, improving SAMMSON knockdown and further decreasing UM cell viability. We found mTOR inhibition to also enhance target knockdown in other cancer cell lines as well as normal cells when combined with lipid nanoparticle complexed or encapsulated ASOs or small interfering RNAs (siRNAs). Our results are relevant to nucleic acid treatment in general and highlight the potential of mTOR inhibition to enhance ASO and siRNA mediated target knockdown.

cancer biology↗

The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival

PurposeLong non-coding RNAs (lncRNAs) can exhibit cell-type and cancer-type specific expression profiles, making them highly attractive as therapeutic targets. Pan-cancer RNA sequencing data revealed broad expression of the SAMMSON lncRNA in uveal melanoma (UM), the most common primary intraocular malignancy in adults. Currently, there are no effective treatments for UM patients with metastatic disease, resulting in a median survival time of 6-12 months. We aimed to investigate the therapeutic potential of SAMMSON inhibition in UM. Experimental DesignThe impact of antisense oligonucleotide (ASO)-mediated SAMMSON inhibition was evaluated in a panel of UM cell lines and patient derived xenograft (PDX) models. Cell proliferation and apoptosis were quantified in vitro and in vivo and complemented with molecular profiles established through RNA-sequencing. SAMMSON interaction partners were identified using ChIRP-MS. ResultsSAMMSON inhibition impaired the growth and viability of a genetically diverse panel of uveal melanoma cell lines. These effects were accompanied by an induction of apoptosis and were recapitulated in two uveal melanoma PDX models through subcutaneous ASO delivery. SAMMSON pulldown revealed several candidate interaction partners, including various proteins involved in mitochondrial translation. Consequently, inhibition of SAMMSON impaired global protein translation levels and mitochondrial function in uveal melanoma cells. ConclusionSAMMSON expression is essential for uveal melanoma cell survival. ASO-mediated silencing of SAMMSON may provide an effective treatment strategy to treat primary and metastatic uveal melanoma patients.

cancer biology↗